Intensity Therapeutics Statistics
NASDAQ: INTSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.68-0.12 (-3.16%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Intensity Therapeutics by the numbers
Intensity Therapeutics has a market capitalization of $12.0 million based on 3.26M shares outstanding. With trailing EPS of $-3.89, Intensity Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.1% below its 50-day average and 36.2% below its 200-day average.
Average daily trading volume is 25.93K shares, or about $95,441 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INTS valuation vs. peer median
| Metric | INTS | Peer median | Difference |
|---|---|---|---|
| Market cap | $12.01M | $12.39M | -3% |
| Avg. volume | 25.93K | 427.91K | -94% |
Peer median across 8 companies: PASG, PLUR, INAB, SNTI, TCRX, BCDA, AIM, BTTC.
Valuation
- Market cap
- $12.01M
- EPS (TTM)
- $-3.89
- Shares outstanding
- 3.26M
Price and trading
- Previous close
- 3.80
- Open
- 3.76
- Day range
- 3.58 – 3.80
- 52-week range
- 3.21 – 43.50
- 52-week change
- -48.35%
- Beta
- —
- Volume
- 19.04K
- Average volume
- 25.93K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 12.01M
- Forward Pe
- -1.85
- Eps
- -3.89
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 43.50
- Week52 Low
- 3.21
- Avg Volume
- 25,935.00
- Shares Outstanding
- 3.26M
- Ma50
- 4.05
- Ma200
- 5.77
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -91.54%
- Pct From52w Low
- 14.64%